The Royals’ rotation depth has taken a hit.
Left-hander Eric Skoglund was suspended for 80 games by MLB for violating the league’s joint drug prevention and treatment program.
Skoglund tested positive for the selective androgen receptor modulators S-22 (Ostarine) and LGD-4033 (Ligandrol), which are both classified as performance-enhancing substances.
#Royals LHP Eric Skoglund has been suspended 80 games. He tested positive for “Selective Androgen Receptor Modulators S-22 (Ostarine) and LGD-4033 (Ligandrol)”.
Dayton Moore statement: pic.twitter.com/1do4k9ujuS
— Tom Martin (@TomKCTV5) January 16, 2019
“Unfortunately, when something like this occurs I immediately think about how much work and dedication our medical staff does communicating to the players about the importance of being careful about what they put in their bodies,” Royals general manager Dayton Moore wrote in a statement. “I’m appreciative that professional baseball players are tested more frequently than any professional athlete and we should all be thankful that testing is working.
“Eric is a tremendous young man and he unknowingly made a mistake and he will have to accept his suspension, work hard and be ready to go after the suspension is served. We remain proud of Eric as a person and will support him as an organization.”
Skoglund was in the running for a rotation spot with the Royals this season and at least a spot in the bullpen.
He went 1-6 with a 5.14 ERA in 14 games (13 starts) for Kansas City last year. He was very good in the final month of the season as he went 0-1 with a 1.33 ERA in five games (four starts) and 20 1/3 innings pitched.
Skoglund was a top-5 prospect for the Royals over the last two seasons. He was originally a third-round pick in 2014.